Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?

Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?

Objective. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a marker of vascular inflammation, is associated with cardiovascular disease. This prospective study of an inception cohort aimed to investigate whether the level of Lp-PLA2 is associated with subclinical atherosclerosis in patients with...

Full description

Bibliographic Details
Main Authors:	Södergren, Anna, Karp, Kjell, Bengtsson, Christine, Möller, Bozena, Rantapää-Dahlqvist, Solbritt, Wållberg-Jonsson, Solveig
Format:	Online
Language:	English
Published:	Hindawi Publishing Corporation 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609366/

Similar Items

Co-morbidity in patients with early rheumatoid arthritis - inflammation matters
by: Innala, Lena, et al.
Published: (2016)

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study
by: Innala, Lena, et al.
Published: (2014)

Abdominal obesity, gender and the risk of rheumatoid arthritis – a nested case–control study
by: Ljung, Lotta, et al.
Published: (2016)

Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis
by: Grimsholm, Ola, et al.
Published: (2005)

Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case–control study
by: Heidi Kokkonen, et al.
Published: (2017-06-01)

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study
by: Innala, Lena, et al.
Published: (2011)

Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study
by: Bokarewa, Maria, et al.
Published: (2014)

Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis
by: Surowiec, Izabella, et al.
Published: (2016)

PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease
by: Johansson, Martin, et al.
Published: (2006)

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study
by: Ljung, Lotta, et al.
Published: (2014)

Diagnostic properties of metabolic perturbations in rheumatoid arthritis
by: Madsen, Rasmus K, et al.
Published: (2011)

Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
by: Francesca Romana Spinelli, et al.
Published: (2017-05-01)

Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study
by: Wahlin, Bengt, et al.
Published: (2016)

Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis
by: Kokkonen, Heidi, et al.
Published: (2011)

Vitamin D in individuals before onset of rheumatoid arthritis - relation to vitamin D binding protein and its associated genetic variants
by: Mikael Brink, et al.
Published: (2018-09-01)

Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis
by: Juneblad, Kristina, et al.
Published: (2011)

The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
by: Kokkonen, Heidi, et al.
Published: (2007)

Correction: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
by: Kokkonen, Heidi, et al.
Published: (2007)

Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
by: Ärlestig, Lisbeth, et al.
Published: (2011)

Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study
by: Kastbom, Alf, et al.
Published: (2012)

Erratum to: Concentration of antibodies against Porphyromonas gingivalisis increased before the onset of symptoms of rheumatoid arthritis
by: Johansson, Linda, et al.
Published: (2016)

Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis
by: Johansson, Linda, et al.
Published: (2016)

Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis
by: Johansson, Linda, et al.
Published: (2016)

Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis
by: Kokkonen, Heidi, et al.
Published: (2015)

Atherosclerosis in Rheumatoid Arthritis
by: González-Gay, Miguel A., et al.
Published: (2012)

Adiponectin and Atherosclerosis in Rheumatoid Arthritis
by: Dessein, Patrick H., et al.
Published: (2014)

Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
by: Yamamoto, Kei, et al.
Published: (2011)

Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
by: Brink, Mikael, et al.
Published: (2016)

Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis
by: González-Gay, Miguel A, et al.
Published: (2012)

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis
by: Berglin, Ewa, et al.
Published: (2004)

The application value of MRI in the diagnosis of subclinical inflammation in patients with rheumatoid arthritis in remission
by: Huimei Zhang, et al.
Published: (2018-07-01)

Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors
by: Sulaiman Sahari, Narisa, et al.
Published: (2014)

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
by: Beatriz Tejera-Segura, et al.
Published: (2017-05-01)

Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
by: Francesca Romana Spinelli, et al.
Published: (2017-06-01)

Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity
by: Ristić, Gorica G., et al.
Published: (2015)

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis
by: López-Mejías, Raquel, et al.
Published: (2016)

Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients
by: López-Mejías, Raquel, et al.
Published: (2015)

Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker
by: Mohan, Alladi, et al.
Published: (2014)

Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment
by: Forsgren, Sture, et al.
Published: (2011)

Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis
by: Mangnus, Lukas, et al.
Published: (2015)